ArticleJournal of neurodevelopmental disorders2017
Arbaclofen in fragile X syndrome: results of phase 3 trials.
Elizabeth Berry-Kravis et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
99 papers cite itlatest 60 shown
this papertrialcites it